PDC*line Pharma picks up $22.2 mln Series B

PDC*line Pharma, a French and Belgian clinical-stage biotech company, has raised $22.2 million in Series B funding.

PDC*line Pharma, a French and Belgian clinical-stage biotech company, has raised $22.2 million in Series B funding. The investors included Korean Investment Partners, Shinhan-Cognitive Start-up Fund and UTC 2019 BIOVENTUREFUND.

Source: Press Release